ELISpot Plus:小鼠IL-4(ALP)-通過(guò)ELISpot實(shí)驗(yàn)檢測(cè)分泌小鼠IL-4的細(xì)胞數(shù)量

ELISpot Plus:小鼠IL-4(ALP)：用于通過(guò)ELISpot實(shí)驗(yàn)檢測(cè)分泌小鼠IL-4的細(xì)胞數(shù)量。僅供研究使用，不適用于診斷程序。

艾美捷ELISpot Plus:小鼠IL-4(ALP)：

貨號(hào)：MBT-3311-4APW-2

應(yīng)用：ELISpot

檢測(cè)指標(biāo)：IL-4

反應(yīng)性：小鼠

特異性：該試劑盒基于一對(duì)特異性針對(duì)小鼠IL-4的單克隆抗體。

運(yùn)輸條件：常溫運(yùn)輸。

儲(chǔ)存條件：收到后請(qǐng)將抗體、酶結(jié)合物和底物在4-8℃保存。ELISpot板可在室溫下保存。

有效期：自收到之日起至少18個(gè)月。

ELISpot Plus:小鼠IL-4(ALP)性能驗(yàn)證：

小鼠脾細(xì)胞（每孔20萬(wàn)細(xì)胞）在有或無(wú)刀豆蛋白A（ConA）的條件下孵育過(guò)夜，通過(guò)ELISpot實(shí)驗(yàn)分析分泌IL-4的細(xì)胞數(shù)量。

部分文獻(xiàn)參考：

Dai et al,Lipid nanoparticles as adjuvant of norovirus VLPvaccine augment cellular and humoral immune responses in aTLR9-and type IIFN-dependent pathway Journal of virology 2024

Liet al,A substitution at the cytoplasmic tailof the spike protein enhances SARS-CoV-2 infectivity and immunogenicityEBioMedicine 2024

Luo et al,mRNA-based platform for preventing and treating Staphylococcus aureus by targeted staphylococal enterotoxin BFrontiers in immunology 2024

Hurst et al,Comparison of a SARS-CoV-2mRNA booster immunization containing additional antigens to a spike-basedmRNA vaccine against Omicron BA.5infection in hACE2 mice.PloS one 2024

An et al,A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2Signal transduction and targeted therapy 2024